{
    "2020-10-28": [
        [
            {
                "time": "2020-09-15",
                "original_text": "The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "GlaxoSmithKline",
                        "COVID-19",
                        "vaccine",
                        "Gilead",
                        "earnings",
                        "Biodesix"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-16",
                "original_text": "Novartis Strikes Deal To Commercialize Molecular Partners' COVID-19 Drug Candidates",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Molecular Partners",
                        "COVID-19",
                        "drug candidates"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-16",
                "original_text": "Molecular Partners jumps after Novartis deal for potential COVID-19 drugs",
                "features": {
                    "keywords": [
                        "Molecular Partners",
                        "Novartis",
                        "COVID-19",
                        "drugs"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-16",
                "original_text": "Novartis announces collaboration with Molecular Partners to develop two DARPinÂ® therapies designed for potential use against COVID-19",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Molecular Partners",
                        "DARPin",
                        "therapies",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}